Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
Two leading Oncology professors, supported by Manchester BRC’s Advanced Radiotherapy Theme, have been honoured by the European Society for Radiotherapy and Oncology (ESTRO).
Continue reading full article: BRC Oncology professors receive prestigious honours from European Society
A leading cancer professor from Manchester BRC features in a documentary following TV presenter Julia Bradbury’s personal breast cancer journey.
Continue reading full article: BRC Cancer Professor features in Julia Bradbury breast cancer documentary
Professor Chris Griffiths OBE, BRC Dermatology Theme Lead, has become Honorary Life Vice President of the Psoriasis Association.
Continue reading full article: Psoriasis Association honours BRC Dermatology Theme Lead
A world-first genetic test developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.
Continue reading full article: NHS develops world-first bedside genetic test to prevent babies going deaf
A BRC Dermatology Theme researcher has been awarded a £81,000 grant from the British Skin Foundation charity to support research into the skin condition Alopecia Areata.
Continue reading full article: Dermatology researcher receives British Skin Foundation grant for national alopecia research
Continuing regular contributions from our BRC Musculoskeletal (MSK) theme researchers, Dr Alexander Oldroyd speaks to Arthritis Digest magazine about how technology could potentially help predict flares in patients with the autoimmune condition, myositis.
Continue reading full article: Myositis and remote patient monitoring – Dr Alexander Oldroyd speaks to Arthritis Digest
Three researchers from Manchester Biomedical Research Centre (BRC) have been appointed Senior Investigators by the National Institute for Health Research (NIHR).
Continue reading full article: Manchester BRC researchers receive prestigious national appointments
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
Continue reading full article: Global trials show drug eases symptoms of chronic cough